Skip to main content
. 2019 Aug 1;32(4):224–241. doi: 10.1089/jamp.2018.1488

FIG. 1.

FIG. 1.

Surface models of the mixer-heater portion of the combination HFNC and pharmaceutical aerosol device (combination device) denoted as (a) Design 1, (b) Design 2, and (c) Design 3. The mixer-heater is intended to produce <5% depositional loss of the nebulized dose and fully evaporate the aerosol into dried particles. HFNC, high-flow nasal cannula.